Notice Information
Notice Title
NHS Framework for the North of England, Branded Medicine
Notice Description
HS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi(r))
Lot Information
CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B
CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual TrancheCM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r))-SofECM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months.
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months.
CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), LondonCM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months.
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months.
CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), MaECM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02e103
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/005550-2022
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £863,999,552 £100M-£1B
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 1 Mar 20223 years ago
- Submission Deadline
- 20 Oct 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 7 Feb 20224 years ago
- Contract Period
- 1 Mar 2022 - 28 Feb 2023 6-12 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Contact Name
- Giorgie Rushton
- Contact Email
- giorgie.rushton2@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD7 Merseyside
- Small Region (ITL 3)
- TLD71 East Merseyside
- Delivery Location
- Not specified
-
- Local Authority
- Halton
- Electoral Ward
- Halton Lea
- Westminster Constituency
- Runcorn and Helsby
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02e103-2022-03-01T12:15:29Z",
"date": "2022-03-01T12:15:29Z",
"ocid": "ocds-h6vhtk-02e103",
"description": "RESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue title to select- review opportunity details and click \"Register Interest\"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select \"Register\" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S(r) Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-02e103",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS Framework for the North of England, Branded Medicine",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "HS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi(r))",
"value": {
"amount": 863999552,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"title": "CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B",
"description": "CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months",
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2024-02-29T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "2",
"title": "CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"description": "CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.",
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2023-02-28T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "3",
"title": "CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r))-SofE",
"description": "CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months.",
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "4",
"title": "CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London",
"description": "CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months.",
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2023-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "5",
"title": "CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), MaE",
"description": "CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.",
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2023-02-28T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points"
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points"
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points"
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points"
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points"
},
"relatedLot": "5"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "http://health.atamis.co.uk",
"communication": {
"atypicalToolUrl": "http://health.atamis.co.uk"
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
}
],
"contractTerms": {
"performanceTerms": "Selection criteria as stated in the procurement documents",
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2021-10-20T13:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2021-10-20T13:00:00+01:00"
},
"bidOpening": {
"date": "2021-10-20T13:00:00+01:00",
"address": {
"streetAddress": "Runcorn"
},
"description": "Commercial Medicines Unit Employee"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)",
"identifier": {
"legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"address": {
"streetAddress": "2nd Floor, Rutland House",
"locality": "Runcorn",
"region": "UK",
"postalCode": "WA7 2ES",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Giorgie Rushton",
"email": "giorgie.rushton2@nhs.net",
"url": "http://health.atamis.co.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-497",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "generaloffice@administrativecourtoffice.justice.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.gov.uk/courts-tribunals"
}
},
{
"id": "GB-FTS-28645",
"name": "Biogen",
"identifier": {
"legalName": "Biogen"
},
"address": {
"locality": "Maidenhead",
"region": "UKJ11",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28655",
"name": "Merck Serono Limited",
"identifier": {
"legalName": "Merck Serono Limited"
},
"address": {
"locality": "Feltham",
"region": "UKI6",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28654",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"locality": "Slough",
"region": "UKJ1",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28644",
"name": "UL Global Pharma",
"identifier": {
"legalName": "UL Global Pharma"
},
"address": {
"locality": "Hertfordshire",
"region": "UKH23",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-28652",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"locality": "Garden City",
"region": "UKH2",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28647",
"name": "Bayer Ltd",
"identifier": {
"legalName": "Bayer Ltd"
},
"address": {
"locality": "Reading",
"region": "UKJ11",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28646",
"name": "Merck Sharpe and Dohme (UK) Limited",
"identifier": {
"legalName": "Merck Sharpe and Dohme (UK) Limited"
},
"address": {
"locality": "London",
"region": "UKI31",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28651",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"locality": "Kent",
"region": "UKJ4",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4073",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"locality": "Devon",
"region": "UKK4",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28649",
"name": "Novo Nordisk",
"identifier": {
"legalName": "Novo Nordisk"
},
"address": {
"locality": "Gatwick",
"region": "UKJ2",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28648",
"name": "Napp Pharmaceuticals Ltd",
"identifier": {
"legalName": "Napp Pharmaceuticals Ltd"
},
"address": {
"locality": "Cambridge",
"region": "UKH12",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28657",
"name": "Eli Lilly and Company Ltd",
"identifier": {
"legalName": "Eli Lilly and Company Ltd"
},
"address": {
"locality": "Basingstoke",
"region": "UKE12",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28659",
"name": "Ipsen",
"identifier": {
"legalName": "Ipsen"
},
"address": {
"locality": "Slough",
"region": "UKJ1",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma ltd t/a Sanofi"
},
"address": {
"locality": "Reading",
"region": "UKJ11",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited",
"identifier": {
"legalName": "Teva UK Limited"
},
"address": {
"locality": "Castleford",
"region": "UKE4",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28661",
"name": "CST Pharma Limited",
"identifier": {
"legalName": "CST Pharma Limited"
},
"address": {
"locality": "Walsall",
"region": "UKG24",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-19357",
"name": "Takeda UK Ltd",
"identifier": {
"legalName": "Takeda UK Ltd"
},
"address": {
"locality": "London",
"region": "UKI3",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28662",
"name": "Gilead Sciences Limited",
"identifier": {
"legalName": "Gilead Sciences Limited"
},
"address": {
"locality": "Holborn",
"region": "UKI31",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7487",
"name": "Thornton and Ross Ltd",
"identifier": {
"legalName": "Thornton and Ross Ltd"
},
"address": {
"locality": "Huddersfield",
"region": "UKE4",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"locality": "High Wycombe",
"region": "UKJ13",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-28656",
"name": "Bristol Myers Squibb",
"identifier": {
"legalName": "Bristol Myers Squibb"
},
"address": {
"locality": "Uxbridge",
"region": "UKI74",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-40746",
"name": "GlaxoSmithKline UK Limited",
"identifier": {
"legalName": "GlaxoSmithKline UK Limited"
},
"address": {
"locality": "London",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-23571",
"name": "Amgen Ltd",
"identifier": {
"legalName": "Amgen Ltd"
},
"address": {
"locality": "Cambridge",
"region": "UKH12",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-44973",
"name": "UCB Pharma Ltd",
"identifier": {
"legalName": "UCB Pharma Ltd"
},
"address": {
"locality": "Slough",
"region": "UKJ1",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7488",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"locality": "London",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-45600",
"name": "Gedeon Richter UK Ltd",
"identifier": {
"legalName": "Gedeon Richter UK Ltd"
},
"address": {
"locality": "Maida Vale - London",
"region": "UKI3",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-28665",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)",
"identifier": {
"legalName": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
"address": {
"locality": "Cambridgeshire",
"region": "UKH12",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
}
],
"buyer": {
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"language": "en",
"awards": [
{
"id": "005550-2022-CM/PHR/20/5600-1",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28645",
"name": "Biogen"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-2",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28655",
"name": "Merck Serono Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-3",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28654",
"name": "Celltrion Healthcare United Kingdom Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-4",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28644",
"name": "UL Global Pharma"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-5",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28652",
"name": "Roche Products Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-6",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28647",
"name": "Bayer Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-7",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28646",
"name": "Merck Sharpe and Dohme (UK) Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-8",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28651",
"name": "Pfizer Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-9",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4073",
"name": "Accord-UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-10",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28649",
"name": "Novo Nordisk"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-11",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28648",
"name": "Napp Pharmaceuticals Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-12",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28657",
"name": "Eli Lilly and Company Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-13",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28659",
"name": "Ipsen"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-14",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-15",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-16",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28661",
"name": "CST Pharma Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-17",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-19357",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-18",
"relatedLots": [
"1"
],
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28662",
"name": "Gilead Sciences Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-19",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7487",
"name": "Thornton and Ross Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-20",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-21",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28654",
"name": "Celltrion Healthcare United Kingdom Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-22",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28656",
"name": "Bristol Myers Squibb"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-23",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-40746",
"name": "GlaxoSmithKline UK Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-24",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28652",
"name": "Roche Products Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-25",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28646",
"name": "Merck Sharpe and Dohme (UK) Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-26",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28651",
"name": "Pfizer Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-27",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4073",
"name": "Accord-UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-28",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28648",
"name": "Napp Pharmaceuticals Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-29",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28657",
"name": "Eli Lilly and Company Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-30",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-23571",
"name": "Amgen Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-31",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-32",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-44973",
"name": "UCB Pharma Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-33",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-34",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7488",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-35",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-19357",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-36",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-45600",
"name": "Gedeon Richter UK Ltd"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600/02-37",
"relatedLots": [
"2"
],
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-28665",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-38",
"relatedLots": [
"3"
],
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r))-SofE",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-39",
"relatedLots": [
"4"
],
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "005550-2022-CM/PHR/20/5600-40",
"relatedLots": [
"5"
],
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), MaE",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4069",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
}
],
"contracts": [
{
"id": "005550-2022-CM/PHR/20/5600-1",
"awardID": "005550-2022-CM/PHR/20/5600-1",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-2",
"awardID": "005550-2022-CM/PHR/20/5600-2",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-3",
"awardID": "005550-2022-CM/PHR/20/5600-3",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-4",
"awardID": "005550-2022-CM/PHR/20/5600-4",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-5",
"awardID": "005550-2022-CM/PHR/20/5600-5",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-6",
"awardID": "005550-2022-CM/PHR/20/5600-6",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-7",
"awardID": "005550-2022-CM/PHR/20/5600-7",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-8",
"awardID": "005550-2022-CM/PHR/20/5600-8",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-9",
"awardID": "005550-2022-CM/PHR/20/5600-9",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-10",
"awardID": "005550-2022-CM/PHR/20/5600-10",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-11",
"awardID": "005550-2022-CM/PHR/20/5600-11",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-12",
"awardID": "005550-2022-CM/PHR/20/5600-12",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-13",
"awardID": "005550-2022-CM/PHR/20/5600-13",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-14",
"awardID": "005550-2022-CM/PHR/20/5600-14",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-15",
"awardID": "005550-2022-CM/PHR/20/5600-15",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-16",
"awardID": "005550-2022-CM/PHR/20/5600-16",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-17",
"awardID": "005550-2022-CM/PHR/20/5600-17",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-18",
"awardID": "005550-2022-CM/PHR/20/5600-18",
"title": "NHS Framework for the North of England, Branded Medicines -Tranche B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-19",
"awardID": "005550-2022-CM/PHR/20/5600/02-19",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-20",
"awardID": "005550-2022-CM/PHR/20/5600/02-20",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-21",
"awardID": "005550-2022-CM/PHR/20/5600/02-21",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-22",
"awardID": "005550-2022-CM/PHR/20/5600/02-22",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-23",
"awardID": "005550-2022-CM/PHR/20/5600/02-23",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-24",
"awardID": "005550-2022-CM/PHR/20/5600/02-24",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-25",
"awardID": "005550-2022-CM/PHR/20/5600/02-25",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-26",
"awardID": "005550-2022-CM/PHR/20/5600/02-26",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-27",
"awardID": "005550-2022-CM/PHR/20/5600/02-27",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-28",
"awardID": "005550-2022-CM/PHR/20/5600/02-28",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-29",
"awardID": "005550-2022-CM/PHR/20/5600/02-29",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-30",
"awardID": "005550-2022-CM/PHR/20/5600/02-30",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-31",
"awardID": "005550-2022-CM/PHR/20/5600/02-31",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-32",
"awardID": "005550-2022-CM/PHR/20/5600/02-32",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-33",
"awardID": "005550-2022-CM/PHR/20/5600/02-33",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-34",
"awardID": "005550-2022-CM/PHR/20/5600/02-34",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-35",
"awardID": "005550-2022-CM/PHR/20/5600/02-35",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-36",
"awardID": "005550-2022-CM/PHR/20/5600/02-36",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600/02-37",
"awardID": "005550-2022-CM/PHR/20/5600/02-37",
"title": "NHS Framework for the NOFE, Branded Medicines-Annual Tranche",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-38",
"awardID": "005550-2022-CM/PHR/20/5600-38",
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r))-SofE",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-39",
"awardID": "005550-2022-CM/PHR/20/5600-39",
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
},
{
"id": "005550-2022-CM/PHR/20/5600-40",
"awardID": "005550-2022-CM/PHR/20/5600-40",
"title": "NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), MaE",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-02-07T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "4",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "7",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "10",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "13",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "16",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "19",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "22",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "25",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "28",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "31",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "34",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "37",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "40",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "43",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "46",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "49",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "52",
"measure": "bids",
"relatedLot": "1",
"value": 23
},
{
"id": "55",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "58",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "61",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "64",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "67",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "70",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "73",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "76",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "79",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "82",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "85",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "88",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "91",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "94",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "97",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "100",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "103",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "106",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "109",
"measure": "bids",
"relatedLot": "2",
"value": 20
},
{
"id": "112",
"measure": "bids",
"relatedLot": "3",
"value": 1
},
{
"id": "114",
"measure": "bids",
"relatedLot": "4",
"value": 1
},
{
"id": "116",
"measure": "bids",
"relatedLot": "5",
"value": 1
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "5",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "8",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "11",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "14",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "17",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "20",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "23",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "26",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "29",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "32",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "35",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "38",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "41",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "44",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "47",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "50",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "53",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "56",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "59",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "62",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "65",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "68",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "71",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "74",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "77",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "80",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "83",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "86",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "89",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "92",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "95",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "98",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "101",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "104",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "107",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "110",
"measure": "smeBids",
"relatedLot": "2",
"value": 2
},
{
"id": "3",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "6",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "9",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "12",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "15",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "18",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "21",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "24",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "27",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "30",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "33",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "36",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "39",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "42",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "45",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "48",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "51",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "54",
"measure": "electronicBids",
"relatedLot": "1",
"value": 23
},
{
"id": "57",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "60",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "63",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "66",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "69",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "72",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "75",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "78",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "81",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "84",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "87",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "90",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "93",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "96",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "99",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "102",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "105",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "108",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "111",
"measure": "electronicBids",
"relatedLot": "2",
"value": 20
},
{
"id": "113",
"measure": "electronicBids",
"relatedLot": "3",
"value": 1
},
{
"id": "115",
"measure": "electronicBids",
"relatedLot": "4",
"value": 1
},
{
"id": "117",
"measure": "electronicBids",
"relatedLot": "5",
"value": 1
}
]
}
}